Global Med Technologies, Inc. (OTC BB: GLOB), an international medical software company, is focused on developing regulated and non-regulated software products and services for application in the medical field. The company’s products are currently deployed in 20 countries and serve more than 1,600 transfusion centers, blood banks and laboratories. Global Med’s U.S. division provides Vein-to- Vein® tracking through its Donor Doc(TM), SafeTrace®, SafeTrace Tx® and ElDorado Donor(TM) software products. For further information, visit the Company’s web site at www.wyndgate.com.
- 17 years ago
QualityStocks
Global Med Technologies, Inc. (OTC BB: GLOB)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Prepares Reimbursement Submission for Nu.Q Cancer Assays in France
VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that it is preparing a reimbursement submission for its Nu.Q®…
-
QualityStocksNewsBreaks – Brand Engagement Network Inc. (NASDAQ: BNAI) Reports Warrant Exercises, Debt Conversion, and Public Warrants Update
Brand Engagement Network Inc. (NASDAQ: BNAI) announced on Wednesday that it generated approximately $1.46 million…
-
Soligenix (NASDAQ: SNGX) Positioning for Impact in Growing Rare-Disease Landscape
The World Health Organization’s recent recognition of rare diseases as a global health priority underscores…